Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin and Paclitaxel for Metastatic Germ Cell Tumors
NCT00611962Phase 2Completed
- Sponsor
- Sanofi
- Start
- Dec 2000
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of oxaliplatin and paclitaxel in Germ Cell Tumor (GCT), sponsored by Sanofi. Primary endpoint: Tumor Response Rate. Started Dec 2000; status: completed.
02
Drugs
oxaliplatinpaclitaxel
03
Conditions
Germ Cell Tumor (GCT)
Beyond the preview
Go deeper on NCT00611962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00611962.